These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1801455)

  • 1. [Phospholipid thrombocyte activating factor, its analogs and antagonists: prospects of their use in medicine].
    Kulikov VI; Muzia GI
    Vestn Akad Med Nauk SSSR; 1991; (10):13-7. PubMed ID: 1801455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Platelet-activating factor (PAF) antagonists].
    Terasawa M
    Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):379-87. PubMed ID: 1850862
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of platelet-activating factor (PAF) antagonists and nitric oxide in cardiac actions of PAF. Electrophysiological and morphological study.
    Kecskeméti V; Balogh I
    J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):723-35. PubMed ID: 11192945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAF-induced amplification of mediator release in septic shock: prevention or downregulation by PAF antagonists.
    Koltai M; Hosford D; Braquet P
    J Lipid Mediat; 1993; 6(1-3):183-98. PubMed ID: 8357981
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of platelet activating factor antagonists on the protamine sulphate stimulated release of histamine from peritoneal mast cells of rats in vitro.
    Lohde C; Bahr T; Labes D; Grupe R
    Arzneimittelforschung; 1992 Jan; 42(1):27-31. PubMed ID: 1375025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell adhesion by membrane-bound paf-acether.
    Ninio E; Leyravaud S; Bidault J; Jurgens P; Benveniste J
    Int Immunol; 1991 Nov; 3(11):1157-63. PubMed ID: 1760410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAF antagonists as possible inhibitors of corneal epithelial defects and ulceration.
    Bazan HE; Tao Y
    J Ocul Pharmacol Ther; 1997 Jun; 13(3):277-85. PubMed ID: 9185044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of platelet activating factor antagonists on arachidonic acid-induced platelet aggregation and TXA2 formation.
    Heinroth-Hoffmann I; Hauser A; Mest HJ
    Prostaglandins Leukot Essent Fatty Acids; 1990 Nov; 41(3):181-2. PubMed ID: 2149184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From ginkgolides to N-substituted piperidino-thieno diazepines, a new series of highly potent dual antagonists.
    Braquet P; Laurent JP; Rolland A; Martin C; Pommier J; Hosford D; Esanu A
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():929-37. PubMed ID: 1825436
    [No Abstract]   [Full Text] [Related]  

  • 10. PAF antagonism as an approach to the treatment of airway hyperreactivity.
    Meade CJ; Heuer H
    Am Rev Respir Dis; 1991 Mar; 143(3 Pt 2):S79-82. PubMed ID: 2003696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of PAF-antagonists in endotoxin shock--ovine and rat experiments.
    Bahrami S; Redl H; Thurnher M; Vogl C; Paul E; Schiesser A; Schlag G
    Prog Clin Biol Res; 1989; 308():931-6. PubMed ID: 2780740
    [No Abstract]   [Full Text] [Related]  

  • 12. PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. II. Relationships between chemical structure and inhibition of PAF-induced human platelet activation.
    Ostermann G; Hofmann B; Kertscher HP; Till U
    J Lipid Mediat; 1991; 3(2):225-37. PubMed ID: 1797154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relevance of eicosanoids including PAF for the biochemical regulation of cardiac rhythm.
    Mest HJ; Riedel A; Meyer E; Hoffmann IH; Mentz G; Mentz P; Tschorn W; Sperling J
    Prog Clin Biol Res; 1989; 301():475-9. PubMed ID: 2798457
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperalgesia induced by Bothrops jararaca venom in rats: role of eicosanoids and platelet activating factor (PAF).
    Teixeira CF; Cury Y; Oga S; Jancar S
    Toxicon; 1994 Apr; 32(4):419-26. PubMed ID: 8052996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation.
    Golino P; Ambrosio G; Ragni M; Pascucci I; Triggiani M; Oriente A; McNatt J; Buja LM; Condorelli M; Chiariello M
    Circulation; 1993 Sep; 88(3):1205-14. PubMed ID: 8353882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAF-cytokine autocatalytic feed-back network in septic shock: involvement in acute renal failure.
    Koltai M; Pirotzky E; Braquet P
    Nephrol Dial Transplant; 1994; 9 Suppl 4():69-72. PubMed ID: 7800272
    [No Abstract]   [Full Text] [Related]  

  • 17. PAF-receptor. 1. 'Cache-oreilles' effect of selected high-potency platelet-activating factor (PAF) antagonists.
    Dive G; Godfroid JJ; Lamotte-Brasseur J; Batt JP; Heymans F; Dupont L; Braquet P
    J Lipid Mediat; 1989; 1(4):201-15. PubMed ID: 2562434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of platelet activating factor antagonists in different models of thrombosis.
    Seth P; Kumari R; Dikshit M; Srimal RC
    Thromb Res; 1994 Dec; 76(6):503-12. PubMed ID: 7900097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for platelet-activating factor as a late-phase mediator of chronic pancreatitis in the rat.
    Zhou WG; Chao W; Levine BA; Olson MS
    Am J Pathol; 1990 Dec; 137(6):1501-8. PubMed ID: 1701964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enterolobin induces rat paw oedema independently of PAF-acether.
    Castro-Faria-Neto HC; Cordeiro RS; Martins MA; Correia-Da-Silva AC; Bozza PT; Sousa MV; Morhy L
    Mem Inst Oswaldo Cruz; 1991; 86 Suppl 2():129-31. PubMed ID: 1841984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.